Assessing the Clinical Robustness of Digital Health Startups: Cross-sectional Observational Analysis.

Abstract

The digital health sector has experienced rapid growth over the past decade. However, health care technology stakeholders lack a comprehensive understanding of clinical robustness and claims across the industry. This analysis aimed to examine the clinical robustness and public claims made by digital health companies. A cross-sectional observational analysis was conducted using company data from the Rock Health Digital Health Venture Funding Database, the US Food and Drug Administration, and the